Cargando…

Comparison of Serum Hemagglutinin and Neuraminidase Inhibition Antibodies After 2010–2011 Trivalent Inactivated Influenza Vaccination in Healthcare Personnel

Background. Most inactivated influenza vaccines contain purified and standardized hemagglutinin (HA) and residual neuraminidase (NA) antigens. Vaccine-associated HA antibody responses (hemagglutination inhibition [HAI]) are well described, but less is known about the immune response to the NA. Metho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laguio-Vila, Maryrose R., Thompson, Mark G., Reynolds, Sue, Spencer, Sarah M., Gaglani, Manjusha, Naleway, Allison, Ball, Sarah, Bozeman, Sam, Baker, Steven, Martínez-Sobrido, Luis, Levine, Min, Katz, Jackie, Fry, Alicia M., Treanor, John J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396428/ https://www.ncbi.nlm.nih.gov/pubmed/25884004 http://dx.doi.org/10.1093/ofid/ofu115

Ejemplares similares

Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture–Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18–65 Years in 2019–2020
por: Naleway, Allison L, et al.
Publicado: (2023)

Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18–64 Years: A Randomized, Open-Label Trial
por: Gaglani, Manjusha, et al.
Publicado: (2022)

Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011–2012 to 2016–2017
por: Gaglani, Manjusha, et al.
Publicado: (2020)

Etymologia: Hemagglutinin and Neuraminidase
por: Henry, Ronnie, et al.
Publicado: (2018)

Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins
por: Gamblin, Steven J., et al.
Publicado: (2010)

1782. Antimicrobial Stewardship Opportunities in Gram-Negative Bacteremia Treatment at a Community Teaching Hospital
por: Ficinski, Matthew, et al.
Publicado: (2022)

Identification of Hemagglutinin Mutations Caused by Neuraminidase Antibody Pressure
por: Wang, Fei, et al.
Publicado: (2021)

Knowledge and Perspectives of Antimicrobial Stewardship: A Comparison of Inpatient vs. Outpatient Providers
por: Datta, Siddhant, et al.
Publicado: (2017)

190. Which antibiotic are you? Evaluation of a global antibiotic awareness personality quiz
por: Langford, Bradley J, et al.
Publicado: (2020)

1789. Current Antibiotic Prescription Practices in Hospitalized Patients with Acute Myeloid Leukemia (AML) and Febrile Neutropenia of Unknown Origin (FN-FUO): Data from a Large Tertiary Community Hospital
por: Portales-Castillo, Carlos, et al.
Publicado: (2022)

Biophysical Measurement of the Balance of Influenza A Hemagglutinin and Neuraminidase Activities
por: Benton, Donald J., et al.
Publicado: (2015)

The Interplay between the Host Receptor and Influenza Virus Hemagglutinin and Neuraminidase
por: Byrd-Leotis, Lauren, et al.
Publicado: (2017)

Antibody-Dependent Cell-Mediated Cytotoxicity to Hemagglutinin of Influenza A Viruses After Influenza Vaccination in Humans
por: Zhong, Weimin, et al.
Publicado: (2016)

Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines
por: Xu, Kangwei, et al.
Publicado: (2018)

Enhanced Inhibition of Influenza A Virus Adhesion by Di- and Trivalent Hemagglutinin Inhibitors
por: Lu, Wenjing, et al.
Publicado: (2019)

Competitive Cooperation of Hemagglutinin and Neuraminidase during Influenza A Virus Entry
por: Du, Ruikun, et al.
Publicado: (2019)

Influenza Hemagglutinin and Neuraminidase: Yin–Yang Proteins Coevolving to Thwart Immunity
por: Kosik, Ivan, et al.
Publicado: (2019)

Influenza A virus hemagglutinin and neuraminidase act as novel motile machinery
por: Sakai, Tatsuya, et al.
Publicado: (2017)

Structural basis for Glycan-receptor binding by mumps virus hemagglutinin-neuraminidase
por: Forgione, Rosa Ester, et al.
Publicado: (2020)

Characterization of Natural and Synthetic Sialoglycans Targeting the Hemagglutinin-Neuraminidase of Mumps Virus
por: Forgione, Rosa Ester, et al.
Publicado: (2021)

Balancing the influenza neuraminidase and hemagglutinin responses by exchanging the vaccine virus backbone
por: Gao, Jin, et al.
Publicado: (2021)

Peripherally Inserted Central Venous Catheters (PICCs): An Opportunity for Antimicrobial Stewardship
por: Brundige, Mary Lourdes, et al.
Publicado: (2017)

1461. Impact of the Ampicillin/Sulbactam Shortage on Antibiotic Prescribing and Clinical Outcomes for Adult Inpatients with Aspiration Pneumonia
por: Staicu, Mary L, et al.
Publicado: (2020)

254. Review of Clinical Outcomes in Patients Treated with Beta-lactam vs Non-beta-lactam Therapy for AmpC Producing Bacterial Bloodstream Infections
por: Staicu, Mary L, et al.
Publicado: (2020)

Hemagglutinin and Neuraminidase Antibodies Are Induced in an Age- and Subtype-Dependent Manner after Influenza Virus Infection
por: Wong, Sook-San, et al.
Publicado: (2020)

Safety of Stopping Antibiotics Prescribed “Just in Case” – Comparison of Mortality, Readmissions and Clostridium difficile in Patients with Accepted Stewardship Interventions Compared with Declined
por: Staicu, Mary, et al.
Publicado: (2017)

Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies
por: Piepenbrink, Michael, et al.
Publicado: (2023)

The 2(nd) sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin-neuraminidase-receptor balance
por: Du, Wenjuan, et al.
Publicado: (2019)

Newcastle Disease Virus Hemagglutinin Neuraminidase as a Potential Cancer Targeting Agent
por: Baradaran, Ali, et al.
Publicado: (2016)

Structure of the Parainfluenza Virus 5 (PIV5) Hemagglutinin-Neuraminidase (HN) Ectodomain
por: Welch, Brett D., et al.
Publicado: (2013)

Influenza A Virus Hemagglutinin–Neuraminidase–Receptor Balance: Preserving Virus Motility
por: de Vries, Erik, et al.
Publicado: (2020)

Adjuvant-Mediated Differences in Antibody Responses to Computationally Optimized Hemagglutinin and Neuraminidase Vaccines
por: Nagashima, Kaito, et al.
Publicado: (2023)

Relative Effectiveness of MF59 Adjuvanted Trivalent Influenza Vaccine vs Nonadjuvanted Vaccines During the 2019–2020 Influenza Season
por: Imran, Mahrukh, et al.
Publicado: (2022)

Relative Risks of COVID-19–Associated Hospitalizations and Clinical Outcomes by Age and Race/Ethnicity—March 2020–March 2021
por: Bozio, Catherine H, et al.
Publicado: (2022)

A Computational Assay that Explores the Hemagglutinin/Neuraminidase Functional Balance Reveals the Neuraminidase Secondary Site as a Novel Anti-Influenza Target
por: Amaro, Rommie E., et al.
Publicado: (2018)

Hemagglutinin stem reactive antibody response in individuals immunized with a seasonal influenza trivalent vaccine
por: Zhao, Xiaopeng, et al.
Publicado: (2015)

Enhanced Potency and Durability of Antibody Response to Seasonal Trivalent Inactivated Influenza Vaccine (TIV) Combined with a Novel Water-in-Oil Adjuvant System at Reduced Hemagglutinin (HA) Doses
por: Gorse, Geoffrey J, et al.
Publicado: (2017)

Positive selection on hemagglutinin and neuraminidase genes of H1N1 influenza viruses
por: Li, Wenfu, et al.
Publicado: (2011)

Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies
por: Kosik, Ivan, et al.
Publicado: (2019)

Drivers of recombinant soluble influenza A virus hemagglutinin and neuraminidase expression in mammalian cells
por: van der Woude, Roosmarijn, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cej2d17nntfhhgfo1spdt55goi